Summary.-A combination of misonidazole and MTDQ (6,6'-methylene-bis-2,2,4 trimethyl-1,2-dihydroquinoline) has been tested for its radiation-sensitizing properties and cytotoxicity, using Chinese hamster V79 cells cultured in vitro.
MISONIDAZOLE (MIS)
is an electronaffinic compound that selectively sensitizes mammalian cells to the lethal effects of X-and y-rays, and is already in use in clinical trials as an adjunct to radiotherapy (Asquith et al., 1974; Brown, 1975; Fowler et al., 1976) . MTDQ (6,6'-methylene-bis-2,2,4 trimethyl-1, 2-dihydroquinoline) is an antioxidant that was initially developed as a food additive, but has recently been the subject of preliminary clinical investigations in Hungary and limited in vitro experimentation in the United States (Bar et al., 1975 (Bar et al., , 1977 Hall et al., 1978) .
It has been shown in numerous biological systems that hypoxic cells are relatively resistant to killing by sparsely ionizing radiations such as X-or y-rays. It is not known with certainty whether human tumours contain viable hypoxie cells that limit their curability by ionizing radiations, but from histological evidence and by analogy with animal tumours it is likely that they do (Thomlinson & Gray, 1955; Evans & Naylor, 1963) . Various methods have been proposed to counter the problem of hypoxic cells. These include the use of high-pressure oxygen chambers, hyperthermia, radiations with a high linear-energy-transfer and, most recently, the introduction of chemical radiosensitizers that interact with radiation to increase specifically the sensitivity of hypoxic cells while not affecting the response of normal cells (Fowler et al., 1976; Churchill-Davidson, 1966) . A number of compounds have been tested as radiosensitizers in vitro and in vivo. Chapman et al. (1973) linked the radiosensitizing properties to the nitro group, whilst Adams and his colleagues defined the properties necessary for a compound to be used clinically, and established the relationship between electron affinity and radiosensitizing efficiency (Adams, 1973; Adams et al., 1976) . As a result of this diverse experimentation, the nitroimidazoles have been shown to possess the necessary properties and have emerged as leading candidates for clinical use. Currently, 2 of these compounds, misonidazole and metronidazole, are undergoing clinical trials in a number of different countries (Urtasun et al., 1976; Thomlinson et al., 1976; Dische et al., 1977) .
In addition to preferentially radiosensitizing hypoxic cells, the nitroimidazoles also exhibit a temperature-dependent cytotoxicity towards cells deficient in oxygen (Hall & Roizin-Towle, 1975; Mohindra & Rauth 1976; Stratford & Adams, 1977; Sutherland, 1974; Hall et at., 1977) . Generally speaking, 2-nitroimidazoles have been demonstrated to be more cytotoxic than the corresponding 5-nitroimidazoles. It has been postulated that the cytotoxicity is due to intermediate metabolites of the nitroreductase enzyme systems which only function in the absence of oxygen. These enzymes catalyse the reduction of the nitro group to the amino group. Two of the known metabolites, namely the nitroso and hydroxylamine intermediates, are known carcinogens and cytotoxic agents (Gillette, 1971; Gillette et al., 1968; Biaglow et al., 1976; Hall et al., 1977; Willson et al., 1974) .
The clinical use of MIS in radiotherapy patients has been limited because of the occurrence of peripheral neuropathy and symptoms arising from central-nervoussystem damage when large doses are given repeatedly. It is thought that the peripheral neuropathy is a consequence of damage to the myelin sheath surrounding the nervous fibres (Urtasun et al., 1978; Hirst et al., 1978; Dische et al., 1977) . It has not been established whether there is a correlation between the neurological toxicity found in patients and the cytotoxicity towards hypoxic cells that has been shown with cell cultures in vitro.
Recent experiments have shown that MTDQ is a radiosensitizer with an effectiveness very similar to that of MIS (Hall et al., 1979) . Its use is limited because relatively low concentrations only can be obtained in the human. However, it shows a very low toxicity compared with MIS and it may be of interest for this reason (Bar et al., 1975) . The present communication describes experiments involving the simultaneous use of MIS and MTDQ in order to determine the sensitizing properties and the cytotoxicity of this combination of 2 widely different agents.
MATERIALS AND METHODS
Standard culture techniques wvere used to grow Chinese hamster V79 cells in GIBCO F-10 culture medium, supplemented with 10% foetal calf serum, and antibiotics (Ham & Puck, 1962) .
For radiation or cytotoxicity experiments under hypoxia, cells were treated in suspension in glass ampoules. To induce hypoxia, a large number of cells was crowded into a small volume of medium so that 02 was reduced to a low level by cell metabolism and respiration. This method has been widely used, and described in detail elsewhere (Hall et al., 1974) . The essential steps are as follows: cells from a number of actively growing, partially confluent, stock flasks were harvested by trypsinization, washed to remove excess trypsin. and the concentration of cells determined by counting with a Coulter electronic cell counter. This cell suspension was then divided into several parts and the cell concentration in each adjusted to 2x 106 cells/ ml, adding one or another drug at an appropriate concentration according to the plan of the particular experiment. MIS dissolved readily in the cell-culture medium, but in the case of MTDQ, the drug had first to be dissolved in a solvent such as Tween-80. This solution was then diluted with medium until the concentration of the Tween-80 represented no more than 0 1% of the culture medium; this was necessary because the solvent per se was found to be cytotoxic. From each of the cell suspensions, containing various concentrations of one drug, 2 drugs, or no drug at all, series of glass ampoules wvere filled by pipetting 1 ml of the cell suspension into each. These ampoules were then handled in the following way in order to render the cells hypoxic. The ampoules were flushed with high-purity N2 plus 500 CO2 in order to displace the air above the cell suspension. Each ampoule was heat-sealed before it was transferred to a water bath at 37 5°C, where it was continuously shaken and tumbled end-to-end to keep the cells in suspension. This procedure was maintained for 1 h to allow the cells to scavenge the 02 dissolved in the medium by normal respiration and metabolism. Proof that this system produces adequate levels of hypoxia is evidenced by an oxygen enhancement ratio (OER) in excess of 3 when aerated and hypoxic cells are exposed to acute doses of 60Cobalt y-rays. A parallel series of ampoules was filled with cells at a concentration of 104/ml; these were gassed with a mixture of air and 5% CO2 before being heat-sealed.
Because of the lower number of cells, these ampoules remained aerated throughout. For the periods of time used in these experiments, the plating efficiency for both groups of cells, aerated and hypoxic, remained high (typically 70%) and unaffected by the experimental conditions used.
Following this procedure the cells were irradiated with y-rays, or subjected to various periods in the water bath at 37 5°C to assess cytotoxicity. The source of y-rays was a 60Cobalt teletherapy unit, directed vertically upwards so that the cells were irradiated through the bottom of the glass ampoules. At a treatment distance of 40 cm the dose rate was computed to be 2-05 Gy/min. Heat treatments were carried out by immersing the ampoules in a water bath at 37 5°C controlled to +0O10C; the ampoules were continuously tumbled and shaken during this heat treatment to prevent attachment of the cells to the glass surface.
At the conclusion of all treatments, each ampoule was agitated on a vortex mixer to resuspend the cells, after which it was opened and various aliquots of the cell suspension plated into Falcon tissue-culture flasks containing fresh growth medium. After incubation for 8 days at 37-5°C, cells were fixed and stained, and the number of macroscopic colonies counted by a projection technique. Fig. 1 and 2 show the results of experiments in which Chinese hamster V79 cells were exposed to graded doses of 60Cobalt y-rays under aerated and hypoxic conditions, in the presence of various concentrations of MIS or MTDQ or a combination of both. In Fig. 3 , the enhancement ratio is plotted as a function of drug concentration for MTDQ alone, or both in combination. The enhancement ratio is defined as the ratio of doses in the absence and presence of the drug required to pro- Fig. 3 were taken from the experimental data in Figs. 1 and 2 . Fig. 4 shows the result of an experiment in which Chinese hamster V79 cells were exposed for various periods of time at 37-5°C to MTDQ alone, MIS alone, or a combination of both. It is evident from the figure that 0 1 mm of MTDQ does not show significant cytotoxicity, whilst the addition of this quantity of the antioxidant completely blocks the substantial cytotoxicity produced by 5 mm of MIS. The data in Fig. 4 are from one large selfcontained experiment, which has however been repeated 5 times with essentially similar results. Fig. 1 (Bar et al., 1975) .
RESULTS

FIG. 2. Continuation of
These preliminary in vitro experiments indicate that the combination of these 2 agents shows additivity of radiosensitizing effects whilst the cytotoxicity is less than that of MIS alone. It is interesting to speculate on the mechanism of this interaction. A previous report from this laboratory (Hall et al., 1977) suggested that both the radiosensitizing and cytotoxic properties of MIS on hypoxic cells are mediated via a common metabolite, the RN02-radical anion (Mason & Holtzman, 1975; Wardman & Clarke, 1976) . When cysteamine, a free-radical scavenger, was added in equimolar concentrations with MIS both the radiosensitization and cytotoxicity of MIS were reversed. MTDQ, on the other hand, only reverses the cytotoxicity of MIS. Since the metabolites of MIS have been implicated as the agents responsible for its toxicity (Hall et al., 1977; Willson et al., 1974) and the radiosensitizing properties are unaffected, it appears that the site of interaction is not the RN02-radical, but is prior to the radical's formation. The enzyme systems responsible for metabolism of drugs exhibit little substrate specificity in their action (Mannering, 1971; Fouts & Brodie, 1957) . Because of their inherent lack of specifity, it is possible that a drug may interact to inhibit or alter the metabolism of a second drug. In Fig. 4 MTDQ protects against the cytotoxic effects of MIS even when it is present at a concentration 1/50 that of the nitroimidazole. The effect is dramatic; the fraction of cells surviving a 5 h treatment with MIS at 5 mm is increased x 100 by the addition of MTDQ at 01 mm. Even when the concentration of MTDQ is decreased to 0-01 mm it still exerts some inhibition of the toxicity of misonidazole. Because of its structure and insolubility and its action at much lower concentrations, MTDQ may compete with MIS for metabolic enzymes. In this way the sensitizing NO2 group of MIS would remain unaffected but the reduction necessary for expression of cytotoxicity would be blocked.
Since MTDQ is an antioxidant, it will be interesting to discover whether other antioxidants commonly used as food additives, such as BHT*, BHAt and ethoxyquin, can also inhibit the cytotoxic action of MIS (Wattenberg, 1972) . At all events the combination of agents whose mode of action may be different offers an exciting extension to the study of the field of hypoxic cell radiosensitizers.
